For the nine months ended March 2026, net sales were \u00a5522,415 million (6.1% YoY increase), operating income was \u00a514,450 million (4.4% YoY decrease), and net income attributable to owners of parent for the quarter was \u00a59,381 million (10.8% YoY decrease).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3360","jir_company_name":"Ship Healthcare Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/3360-20260206-01.pdf","jir_short_summary":"For the nine months ended March 2026, net sales were \u00a5522,415 million (6.1% YoY increase), operating income was \u00a514,450 million (4.4% YoY decrease), and net income attributable to owners of parent for the quarter was \u00a59,381 million (10.8% YoY decrease).","jir_summary":"### Overview of Financial Results\nFor the nine months ended March 2026, net sales amounted to \u00a5522,415 million (6.1% YoY increase), operating income was \u00a514,450 million (4.4% YoY decrease), ordinary income was \u00a515,462 million (6.5% YoY decrease), and net income attributable to owners of parent for the quarter was \u00a59,381 million (10.8% YoY decrease). Although the medical industry continues to face price inflation and labor shortages, signs of future improvement are emerging with the new Takashi administration\u2019s supplementary budget and the announcement of medical fee revisions.\n\n### Segment Performance\nTotal Pack Produce business recorded net sales of \u00a589,898 million (3.0% YoY increase) but profits declined. Medical Supply business posted net sales of \u00a5378,475 million (7.5% YoY increase) with profits increasing. Life Care business reported net sales of \u00a528,158 million (1.9% YoY increase) with profits decreasing. Dispensing Pharmacy business achieved net sales of \u00a525,883 million (2.8% YoY increase) with profits increasing. Operational efficiency has improved through small-scale M&As and restructuring.\n\n### Financial Position and Share-related Information\nTotal assets were \u00a5388,940 million (increase from previous fiscal year-end), net assets were \u00a5149,253 million (decrease from previous fiscal year-end), and equity ratio was 38.1% (decreased 1.0 points). The number of shares outstanding at period-end was 94,350,134 shares, with treasury shares at 2,331,200 shares. The number of shares decreased due to treasury stock acquisitions.\n\n### Earnings Guidance\nFull-year earnings forecast for FY March 2026 remains unchanged: net sales of \u00a5700,000 million (3.2% YoY increase), operating income of \u00a526,000 million (4.9% YoY increase), ordinary income of \u00a526,500 million (1.8% YoY increase), net income attributable to owners of parent of \u00a515,500 million (2.5% YoY increase), and earnings per share of \u00a5166.85.","jir_financial_highlights":"Net Sales: \u00a5522,415 million (6.1% YoY increase)\nOperating Income: \u00a514,450 million (4.4% YoY decrease)\nOrdinary Income: \u00a515,462 million (6.5% YoY decrease)\nNet Income Attributable to Owners of Parent: \u00a59,381 million (10.8% YoY decrease)\nEquity Ratio: 38.1% (1.0 points YoY decrease)\nNumber of Shares Outstanding at Period-End (Common Stock): 94,350,134 shares (Decrease YoY (101,669,400 shares \u2192 94,350,134 shares))\nNumber of Treasury Shares at Period-End: 2,331,200 shares (Decrease YoY (7,319,266 shares \u2192 2,331,200 shares))","jir_category":"","jir_hashtags":"#ShipHealthcareHoldings, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: \u00a5522,415 million (6.1% YoY increase)\nOperating Income: \u00a514,450 million (4.4% YoY decrease)\nNet Income Attributable to Owners of Parent: \u00a59,381 million (10.8% YoY decrease)","jir_meta_title":"Ship Healthcare Holdings FY March 2026 Q3 Financial Results: 6.1% Sales Increase Despite Profit Declines","jir_meta_description":"Ship Healthcare Holdings' FY March 2026 Q3 financial summary. Net sales of \u00a5522,415 million (6.1% YoY up), operating income \u00a514,450 million (down 4.4%), net income \u00a59,381 million (down 10.8%). Full-year earnings forecast unchanged.","jir_og_title":"Ship Healthcare Holdings FY 2026 Q3 Financial Results Announcement","jir_og_description":"FY March 2026 Q3 financial summary. Net sales increased 6.1% YoY to \u00a5522,415 million, while operating income decreased 4.4% to \u00a514,450 million.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025 Q3\\\",\\\"FY March 2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[492272,522415],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025 Q3\\\",\\\"FY March 2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[15121,14450],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025 Q3\\\",\\\"FY March 2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[10517,9381],\\\"borderColor\\\":\\\"#dc3545\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Total Pack Produce Business\\\",\\\"Medical Supply Business\\\",\\\"Life Care Business\\\",\\\"Dispensing Pharmacy Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[89898,378475,28158,25883],\\\"backgroundColor\\\":[\\\"#007bff\\\",\\\"#28a745\\\",\\\"#ffc107\\\",\\\"#17a2b8\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Total Pack Produce Business\\\",\\\"Medical Supply Business\\\",\\\"Life Care Business\\\",\\\"Dispensing Pharmacy Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[4984,4758,1707,3078],\\\"backgroundColor\\\":[\\\"#007bff\\\",\\\"#28a745\\\",\\\"#ffc107\\\",\\\"#17a2b8\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":8812,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-25634","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n